{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:49:35Z","timestamp":1792205375069,"version":"4.4.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bladder cancer (BCa) ranks among the most prevalent cancers in men, with a subset of patients developing distant metastases (DM), resulting in poor prognosis. This study aims to develop and validate a nomogram to predict DM in patients with BCa, utilizing machine learning techniques to identify potential biomarkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical data from patients with BCa diagnosed between January 2010 and December 2015 were retrospectively retrieved from the Surveillance, Epidemiology, and End Results (SEER) database and randomly split into a training cohort (n = 1,619) and an internal validation cohort (n = 694). An external validation cohort (n = 112) was obtained from the Affiliated Hospital of Guangdong Medical University between January 2021 and December 2023. Independent risk factors for DM were identified using univariate and multivariate logistic regression analyses and incorporated into the nomogram. Predictive accuracy was evaluated using calibration curves, and the nomogram's discriminative ability was compared with traditional staging systems by calculating the area under the curve (AUC). <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Tumor size \u2265 3 cm, N stage (N1\u2013N3), and lack of surgery were found to be independent risk factors for DM, all of which were included in the nomogram. ROC curve analysis demonstrated robust predictive performance, with AUC values of 0.732 in the training cohort, 0.750 in the internal validation cohort, and 0.968 in the external validation cohort. Additionally, calibration curves consistently showed good predictive accuracy across all cohorts. Machine learning methods, including LASSO and Random Forest, identified ADH1B as a potential biomarker for BCa, displaying exceptional diagnostic and prognostic performance (AUC = 0.983). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study, based on the SEER database and an external validation cohort, identified independent risk factors for DM in BCa and revealed ADH1B as a novel biomarker, offering new perspectives for clinical prediction and personalized treatment. <\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1607173","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T09:28:54Z","timestamp":1757496534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a risk prediction model for distant metastasis in muscle-invasive bladder cancer: a retrospective study integrating SEER data with external validation cohort and biomarker analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Quanqing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangmeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: A narrative review of diagnostics and treatments","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"Bmj"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Update"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122570","article-title":"Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation","volume":"14","author":"Dong","year":"2023","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210309111731","article-title":"Bladder cancer: update on risk factors, molecular and ultrastructural patterns","volume":"28","author":"Mikhaleva","year":"2021","journal-title":"Curr Med Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0000000000001322","article-title":"Radiologic diagnosis and staging of bladder cancer: an update","volume":"46","author":"Awiwi","year":"2022","journal-title":"J Comput Assist Tomogr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12957-022-02664-5","article-title":"Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature","volume":"20","author":"Xu","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.7875","article-title":"American society of clinical oncology (ASCO) genitourinary cancers symposium: meeting highlights","volume":"16","author":"Kapoor","year":"2022","journal-title":"Can Urol Assoc J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100296","article-title":"Role of immunotherapy in bladder cancer","volume":"26","author":"Rhea","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","article-title":"The 2021 updated european association of urology guidelines on metastatic urothelial carcinoma","volume":"81","author":"Cathomas","year":"2022","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05048-8","article-title":"Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer","volume":"149","author":"Cheng","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1139222","article-title":"Establishment and validation of nomograms to predict survival probability of advanced Malignant pleural mesothelioma based on the SEER database and A chinese medical institution","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1671-8348.2023.01.004","article-title":"Analysis of clinicopathological features and prognostic factors of rectal signet ring cell carcinoma based on SEER database","volume":"52","author":"Zhang","year":"2023","journal-title":"Chongqing Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101689","article-title":"Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer","volume":"5","author":"Yin","year":"2024","journal-title":"Cell Rep Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","article-title":"Network-based machine learning approach to predict immunotherapy response in cancer patients","volume":"13","author":"Kong","year":"2022","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25534","DOI":"10.1038\/s41598-025-08945-9","article-title":"Developing angiogenesis-related prognostic biomarkers and therapeutic strategies in bladder cancer using deep learning and machine learning","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S148856","article-title":"Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: A population-based study","volume":"9","author":"Dong","year":"2017","journal-title":"Cancer Manag Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01485","article-title":"Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial","volume":"40","author":"Funt","year":"2022","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S683","DOI":"10.1016\/j.annonc.2021.08.055","article-title":"659MO avelumab (A) as the basis of neoadjuvant chemotherapy (NAC) regimen in platinum eligible and ineligible patients (pts) with non-metastatic muscle invasive bladder cancer (NM-MIBC)","volume":"32","author":"Martinez Chanza","year":"2021","journal-title":"Ann Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080769","article-title":"Neoadjuvant immunotherapy for muscle-invasive bladder cancer","volume":"57","author":"Peyrottes","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial","volume":"26","author":"van Dijk","year":"2020","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11934-015-0520-z","article-title":"Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy","volume":"16","author":"Soave","year":"2015","journal-title":"Curr Urol Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3560","article-title":"The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.82","article-title":"Landmarks in the treatment of muscle-invasive bladder cancer","volume":"14","author":"Lobo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202011_23795","article-title":"Advanced\/metastatic bladder cancer: current status and future directions","volume":"24","author":"Facchini","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.11969\/j.issn.1673-548X.2021.01.004","article-title":"Advances in the diagnosis of pelvic lymph node metastasis of bladder cancer","volume":"50","author":"Zhang","year":"2021","journal-title":"J Med Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/0391560319887327","article-title":"Spotlight on gender-specific disparities in bladder cancer","volume":"87","author":"Mancini","year":"2020","journal-title":"Urologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.13201\/j.issn.1001-1420.2020.05.006","article-title":"Age factors on the efficacy of patients with bladder cancer after radical surgery and related factors analysis","volume":"35","author":"Wang","year":"2020","journal-title":"J Clin Urol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-5519.2024.05.007","article-title":"Analysis of risk factors for prognosis of bladder carcinoma in situ and construction of nomogram","volume":"40","author":"Zhang","year":"2024","journal-title":"Modern Med Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.11877\/j.issn.1672-1535.2019.17.07.29","article-title":"Relationship between peripheral blood circulating tumor cells and clinical characteristics, recurrence and metastasis of bladder cancer patients","volume":"17","author":"Jin","year":"2019","journal-title":"Cancer Progression"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-9202.2022.04.018","article-title":"Prognostic factors of postoperative patients with bladder cancer","volume":"42","author":"Zhang","year":"2022","journal-title":"Chin J Geriatrics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03721-6","article-title":"The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: A SEER population-based analysis","volume":"39","author":"Shou","year":"2021","journal-title":"World J Urol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.690324","article-title":"Predictive nomogram and risk factors for lymph node metastasis in bladder cancer","volume":"11","author":"Tian","year":"2021","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13010054","article-title":"Bone metastasis in bladder cancer","volume":"13","author":"Yi","year":"2023","journal-title":"J Pers Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.19381\/j.issn.1001-7585.2023.21.022","article-title":"Effect of comprehensive bladder-sparing therapy based on TURBT on postoperative complications and disease recurrence in patients with stage T-2 muscle-invasive bladder cancer","volume":"36","author":"Liu","year":"2023","journal-title":"Med Theory Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-3511.2023.11.022","article-title":"Survival analysis of patients after radical resection of bladder cancer","volume":"35","author":"Zhou","year":"2023","journal-title":"West Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3969\/j.issn.1674-4659.2022.06.0869","article-title":"Effects of different chemotherapy methods on GQOLI-74 score and recurrence rate after bladder-sparing surgery for muscle-invasive bladder cancer","volume":"43","author":"Feng","year":"2022","journal-title":"J Med Forum"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.101107","article-title":"American society of clinical oncology 2022 annual meeting highlights for radiation oncologists","volume":"8","author":"Dove","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2158","article-title":"Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial","volume":"28","author":"Basile","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade2780","article-title":"Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people","volume":"10","author":"Koyanagi","year":"2024","journal-title":"Sci Adv"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i47.6020","article-title":"Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China","volume":"16","author":"Zhang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2016_1289","article-title":"The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of bladder cancer patients","volume":"64","author":"Orywal","year":"2017","journal-title":"Acta Biochim Pol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgw033","article-title":"Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: gene-environment interaction","volume":"37","author":"Masaoka","year":"2016","journal-title":"Carcinogenesis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1607173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T09:29:02Z","timestamp":1757496542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1607173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":49,"alternative-id":["10.3389\/fonc.2025.1607173"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1607173","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"article-number":"1607173"}}